Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Regulatory News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.00 (0.00%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £91.78m
FARN Live PriceLast checked at - London Stock Exchange

Intraday Faron Pharmaceuticals Share Chart

Date   Source Headline
2nd Mar 20217:00 amRNSFaron to Present at H.C. Wainwright Conference
25th Feb 20217:00 amRNSNotice of Full-Year Results and Annual Report
17th Feb 20214:30 pmRNSHolding(s) in Company
12th Feb 20213:00 pmRNSRegistration of Placing Shares
12th Feb 20217:00 amRNSResults of Placing and Issue Price
11th Feb 20214:30 pmRNSProposed Issue and Placing of Shares
26th Jan 20217:00 amRNSUpdate on TRAUMAKINE development
20th Jan 20212:06 pmRNSSecond Price Monitoring Extn
20th Jan 20212:01 pmRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSBexmarilimab (Clevegen) development update
18th Jan 20212:05 pmRNSSecond Price Monitoring Extn
18th Jan 20212:00 pmRNSPrice Monitoring Extension
18th Jan 202111:06 amRNSSecond Price Monitoring Extn
18th Jan 202111:01 amRNSPrice Monitoring Extension
18th Jan 20217:00 amRNSUS Department of Defense to support TRAUMAKINE
4th Jan 20217:00 amRNSFaron to Present at H.C. Wainwright
21st Dec 20207:00 amRNSFaron’s financial calendar for 2021
10th Dec 20207:00 amRNSPresents at ESMO Immuno-Oncology Virtual Congress
23rd Nov 20207:30 amRNSTo Participate in Upcoming Investor Conferences
23rd Nov 20207:00 amRNSBexmarilimab (Clevegen) development update
20th Nov 20207:00 amRNSIssue of Equity
16th Oct 202011:35 amRNSFirst Results from WHO Solidarity Trial
14th Oct 20202:15 pmRNSGrant of options
30th Sep 20209:45 amRNSHolding(s) in Company
24th Sep 20207:15 amRNSExercise of options
24th Sep 20207:00 amRNSHalf-year Report
18th Sep 20207:00 amRNSMATINS trial data presented at ESMO
9th Sep 202012:00 pmRNSFaron to Present at H.C. Wainwright Conference
27th Aug 20207:00 amRNSNotice of Half-Year Report
18th Aug 20207:00 amRNSTraumakine Update
17th Aug 20204:41 pmRNSSecond Price Monitoring Extn
17th Aug 20204:36 pmRNSPrice Monitoring Extension
27th Jul 20207:00 amRNSChange of Adviser
20th Jul 20204:41 pmRNSSecond Price Monitoring Extn
20th Jul 20204:35 pmRNSPrice Monitoring Extension
8th Jul 20203:00 pmRNSManagers’ transactions
16th Jun 20207:01 amRNSFaron hosts virtual R&D Day today
16th Jun 20207:00 amRNSFaron update on pipeline progress ahead of R&D Day
15th Jun 20207:00 amRNSFaron receives EUR 2.1 million funding from BF
11th Jun 20207:00 amRNSFaron selected for EUR2.5 million grant from EIC
1st Jun 20207:00 amRNSMATINS Update
28th May 20207:00 amRNSFaron announces R&D Day to be held in June
20th May 20207:00 amRNSPublication in Intensive Care Medicine
18th May 20204:00 pmRNSResults of the Annual General Meeting
13th May 20201:00 pmRNSExercise of options
12th May 20206:00 pmRNSManagers’ transactions
11th May 202010:00 amRNSFaron receives grant from Business Finland
5th May 20207:00 amRNSClevegen manufacturing agreement
29th Apr 20201:15 pmRNSHolding(s) in Company
27th Apr 20202:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.